Jui Chakraborty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Jui Chakraborty has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Suman Saha
13 shared publicationsRupam Saha
7 shared publications- Sayantan Ray
CSIR-Central Glass and Ceramic Research Institute
6 shared publications Arnab Bhattacharjee
5 shared publicationsSayantan Ray
Department of Bioceramics and Coating Division, CSIR-Central Glass and Ceramics Research Institute, Kolkata – 700032, India
5 shared publicationsDebabrata Basu
Cent Glass & Ceram Res Inst, CSIR, Kolkata 700032, W Bengal, India
4 shared publications
Latest Publications
- Open Access
- 12 June 2025
- Published by Elsevier in Next Materials
- Vol. 8
Unveiling the role of acetyl acetone in the sol-gel derived bismuth oxide doped bioactive glass: Comparative insights into phase, microstructure and elemental distribution
- 12 June 2025
- Published by Elsevier in Next Materials
- Vol. 8
Open AccessUnveiling the role of acetyl acetone in the sol-gel derived bismuth oxide doped bioactive glass: Comparative insights into phase, microstructure and elemental distribution
- 4 September 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (22) , 46858-46868
Multifaceted biomedical applications of bismuth oxide-doped bioactive glass: Synthesis challenges, characterization and potential clinical implications
- 4 September 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (22) , 46858-46868
Multifaceted biomedical applications of bismuth oxide-doped bioactive glass: Synthesis challenges, characterization and potential clinical implications
- 30 June 2024
- Published by Springer Nature
- p. 141-159
Bioactive Glass Incorporated Plexiglass Bone Cement: Value Addition for Osteoporotic Vertebral Compression Fracture: (OVCF)
- 30 June 2024
- Published by Springer Nature
- p. 141-159
Bioactive Glass Incorporated Plexiglass Bone Cement: Value Addition for Osteoporotic Vertebral Compression Fracture: (OVCF)
- 23 January 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (7) , 11625-11638
Cobalt containing antimicrobial bioactive glass coated urinary catheter towards management of catheter associated urinary tract infection (CAUTI): Significant in vitro characterizations
- 23 January 2024
- Published by Elsevier in Ceramics International
- Vol. 50 (7) , 11625-11638
Cobalt containing antimicrobial bioactive glass coated urinary catheter towards management of catheter associated urinary tract infection (CAUTI): Significant in vitro characterizations
- 17 January 2024
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 315, 128942
Bioactive glass incorporated dressing matrix for rapid hemostatic action with antibacterial activity
- 17 January 2024
- Published by Elsevier in Materials Chemistry and Physics
- Vol. 315, 128942
Bioactive glass incorporated dressing matrix for rapid hemostatic action with antibacterial activity
- 17 June 2021
- Published by Taylor & Francis in Transactions of the Indian Ceramic Society
- Vol. 80 (2) , 1-8
Development and Validation of RP-HPLC Method for Estimation of Methotrexate Drug Intercalated in Mg-Al Layered Double Hydroxide Nanoparticles
In the present study, pristine magnesium aluminium layered double hydroxide (Mg-Al LDH, sample A) nanoparticles were synthesized by simple co-precipitation technique followed by intercalation of methotrexate drug (MTX), their detailed physicochemical characterization and development of RP-HPLC method for estimation of MTX intercalated in Mg-Al LDH nanoparticles (sample B). The PXRD analysis showed the basal spacing of 003 plane corresponding to sample A and sample B to be 8.63 Å and 11.39 Å, respectively. Particle size distributions were measured to be 56-75 nm (D50=66.15 nm) in case of sample A and 75-100 nm (D50=87.41 nm) for sample B. Simple, accurate RP-HPLC method was developed for estimation of the MTX drug from sample B, on Agilent HPLC 1200 system with UV detector on L1 column. 0.02 M potassium dihydrogen phosphate solution (pH 3.0) and acetonitrile (85:15 v/v) was used as mobile phase in an isocratic elution mode at a flow rate of 1.0 mL/min at 35°C with a load of 10 μL at 307 nm. The retention time for methotrexate was at 4.44 min. The method was validated as per ICH Q2 (R1) guidelines. The method was found to be linear over a concentration range of 10-100 μg/mL. GRAPHICAL ABSTRACT
- 17 June 2021
- Published by Taylor & Francis in Transactions of the Indian Ceramic Society
- Vol. 80 (2) , 1-8
Development and Validation of RP-HPLC Method for Estimation of Methotrexate Drug Intercalated in Mg-Al Layered Double Hydroxide Nanoparticles
In the present study, pristine magnesium aluminium layered double hydroxide (Mg-Al LDH, sample A) nanoparticles were synthesized by simple co-precipitation technique followed by intercalation of methotrexate drug (MTX), their detailed physicochemical characterization and development of RP-HPLC method for estimation of MTX intercalated in Mg-Al LDH nanoparticles (sample B). The PXRD analysis showed the basal spacing of 003 plane corresponding to sample A and sample B to be 8.63 Å and 11.39 Å, respectively. Particle size distributions were measured to be 56-75 nm (D50=66.15 nm) in case of sample A and 75-100 nm (D50=87.41 nm) for sample B. Simple, accurate RP-HPLC method was developed for estimation of the MTX drug from sample B, on Agilent HPLC 1200 system with UV detector on L1 column. 0.02 M potassium dihydrogen phosphate solution (pH 3.0) and acetonitrile (85:15 v/v) was used as mobile phase in an isocratic elution mode at a flow rate of 1.0 mL/min at 35°C with a load of 10 μL at 307 nm. The retention time for methotrexate was at 4.44 min. The method was validated as per ICH Q2 (R1) guidelines. The method was found to be linear over a concentration range of 10-100 μg/mL. GRAPHICAL ABSTRACT
- Open Access
Efficacy of Bioactive Glass Nanofibers Tested for Oral Mucosal Regeneration in Rabbits with Induced Diabetes
The healing of oral lesions that are associated with diabetes mellitus is a matter of great concern. Bioactive glass is a highly recommended bioceramic scaffold for bone and soft tissue regeneration. In this study, we aimed to assess the efficacy of a novel formula of bioactive glass nanofibers in enhancing oral mucosal wound regeneration in diabetes mellitus. Bioactive glass nanofibres (BGnf) of composition (1–2) mol% of B2O3, (68–69) mol% of SiO2, and (29–30) mol% of CaO were synthesized via the low-temperature sol-gel technique followed by mixing with polymer solution, then electrospinning of the glass sol to produce nanofibers, which were then subjected to heat treatment. X-Ray Diffraction analysis of the prepared nanofibers confirmed its amorphous nature. Microstructure of BGnf simulated that of the fibrin clot with cross-linked nanofibers having a varying range of diameter (500–900 nm). The in-vitro degradation profile of BGnf confirmed its high dissolution rate, which proved the glass bioactivity. Following fibers preparation and characterization, 12 healthy New Zealand male rabbits were successfully subjected to type I diabetic induction using a single dose of intravenous injection of alloxan monohydrate. Two weeks after diabetes confirmation, the rabbits were randomly divided into two groups (control and experimental groups). Bilateral elliptical oral mucosal defects of 10 × 3.5 mm were created in the maxillary mucobuccal fold of both groups. The defects of the experimental group were grafted with BGnf, while the other group of defects considered as a control group. Clinical, histological, and immune-histochemical assessment of both groups of wounds were performed after one, two and three weeks’ time interval. The results of the clinical evaluation of BGnf treated defects showed complete wound closure with the absence of inflammation signs starting from one week postoperative. Control defects, on the other hand, showed an open wound with suppurative exudate. On histological and immunohistochemical level, the BGnf treated defects revealed increasing in cell activity and vascularization with the absence of inflammation signs starting from one week time interval, while the control defects showed signs of suppurative inflammation at one week time interval with diminished vascularization. The results advocated the suitability of BGnf as bioscaffold to be used in a wet environment as the oral cavity that is full of microorganisms and also for an immune-compromised condition as diabetes mellitus.
Open AccessEfficacy of Bioactive Glass Nanofibers Tested for Oral Mucosal Regeneration in Rabbits with Induced Diabetes
The healing of oral lesions that are associated with diabetes mellitus is a matter of great concern. Bioactive glass is a highly recommended bioceramic scaffold for bone and soft tissue regeneration. In this study, we aimed to assess the efficacy of a novel formula of bioactive glass nanofibers in enhancing oral mucosal wound regeneration in diabetes mellitus. Bioactive glass nanofibres (BGnf) of composition (1–2) mol% of B2O3, (68–69) mol% of SiO2, and (29–30) mol% of CaO were synthesized via the low-temperature sol-gel technique followed by mixing with polymer solution, then electrospinning of the glass sol to produce nanofibers, which were then subjected to heat treatment. X-Ray Diffraction analysis of the prepared nanofibers confirmed its amorphous nature. Microstructure of BGnf simulated that of the fibrin clot with cross-linked nanofibers having a varying range of diameter (500–900 nm). The in-vitro degradation profile of BGnf confirmed its high dissolution rate, which proved the glass bioactivity. Following fibers preparation and characterization, 12 healthy New Zealand male rabbits were successfully subjected to type I diabetic induction using a single dose of intravenous injection of alloxan monohydrate. Two weeks after diabetes confirmation, the rabbits were randomly divided into two groups (control and experimental groups). Bilateral elliptical oral mucosal defects of 10 × 3.5 mm were created in the maxillary mucobuccal fold of both groups. The defects of the experimental group were grafted with BGnf, while the other group of defects considered as a control group. Clinical, histological, and immune-histochemical assessment of both groups of wounds were performed after one, two and three weeks’ time interval. The results of the clinical evaluation of BGnf treated defects showed complete wound closure with the absence of inflammation signs starting from one week postoperative. Control defects, on the other hand, showed an open wound with suppurative exudate. On histological and immunohistochemical level, the BGnf treated defects revealed increasing in cell activity and vascularization with the absence of inflammation signs starting from one week time interval, while the control defects showed signs of suppurative inflammation at one week time interval with diminished vascularization. The results advocated the suitability of BGnf as bioscaffold to be used in a wet environment as the oral cavity that is full of microorganisms and also for an immune-compromised condition as diabetes mellitus.